1st Oct 2015 12:07
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons
I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares ('ADSs') of GlaxoSmithKline plc (the 'Company').
On 30 September 2015, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £12.51 per Ordinary Share, and notional ADSs at a price of $37.86 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 July 2015 to 30 September 2015:
Non Executive Director | Ordinary Shares | No. of ADSs |
Sir Philip Hampton | 3,497.202 | |
Professor Sir Roy Anderson | 574.540 | |
Dr Stephanie Burns | 757.793 | |
Stacey Cartwright | 424.660 | |
Lynn Elsenhans | 1,552.170 | |
Judy Lewent | 587.943 | |
Sir Deryck Maughan | 1,829.157 | |
Dr Daniel Podolsky | 1,371.868 | |
Urs Rohner | 524.580 | |
Hans Wijers | 424.660 | |
The Company and the Non-Executive Directors were informed of these allocations on 1 October 2015.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
1 October 2015
Related Shares:
Glaxosmithkline